Patients treated with interferon alfa can develop autoantibodies and autoimmune diseases. We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies. One of these patients had myopathic findings on EMG and focal deficiency of cytochrome c oxidase on muscle biopsy.
|Numero di pagine||2|
|Stato di pubblicazione||Pubblicato - 1995|
- Muscle Fibers, Skeletal
- Myasthenia Gravis
- Succinate Dehydrogenase